Shenzhen Edge Medical repurchases 479,800 H-shares for HK$17.52 million, treasury stock rises to 1.62 million shares

Bulletin Express06-24

Shenzhen Edge Medical Co., Ltd. (Edge Medical-B) disclosed that on 24 June 2026 it bought back 479,800 H-shares on the Hong Kong Stock Exchange. The purchase was executed entirely on-market under the company’s existing share-repurchase mandate dated 16 June 2025.

The repurchased shares were acquired at prices ranging from HK$34.70 to HK$38.00 apiece, translating into a volume-weighted average cost of HK$36.53 per share and an aggregate consideration of HK$17.52 million. All repurchased shares have been retained as treasury stock.

Following the transaction, Edge Medical’s outstanding share count (excluding treasury shares) fell by 0.1469% to 326.15 million shares, while the treasury stock balance increased to 1.62 million shares. The total issued share capital remains unchanged at 327.76 million shares until any future cancellation of treasury shares.

Since receiving shareholder authorisation to repurchase up to 32.36 million shares, the company has cumulatively bought back 1.62 million shares, representing 0.50% of the issued shares outstanding on the mandate date. In accordance with Hong Kong listing rules, Edge Medical is subject to a moratorium on issuing new shares or disposing of treasury shares until 24 July 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1129567789?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-24 19:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1129567789","market":"us","top_or_hot":-1,"title":"Shenzhen Edge Medical repurchases 479,800 H-shares for HK$17.52 million, treasury stock rises to 1.62 million shares","media":"Bulletin Express","content":"<p>Shenzhen Edge Medical Co., Ltd. (Edge Medical-B) disclosed that on 24 June 2026 it bought back 479,800 H-shares on the Hong Kong Stock Exchange. The purchase was executed entirely on-market under the company’s existing share-repurchase mandate dated 16 June 2025.</p>\n<p>The repurchased shares were acquired at prices ranging from HK$34.70 to HK$38.00 apiece, translating into a volume-weighted average cost of HK$36.53 per share and an aggregate consideration of HK$17.52 million. All repurchased shares have been retained as treasury stock.</p>\n<p>Following the transaction, Edge Medical’s outstanding share count (excluding treasury shares) fell by 0.1469% to 326.15 million shares, while the treasury stock balance increased to 1.62 million shares. The total issued share capital remains unchanged at 327.76 million shares until any future cancellation of treasury shares.</p>\n<p>Since receiving shareholder authorisation to repurchase up to 32.36 million shares, the company has cumulatively bought back 1.62 million shares, representing 0.50% of the issued shares outstanding on the mandate date. In accordance with Hong Kong listing rules, Edge Medical is subject to a moratorium on issuing new shares or disposing of treasury shares until 24 July 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shenzhen Edge Medical repurchases 479,800 H-shares for HK$17.52 million, treasury stock rises to 1.62 million shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShenzhen Edge Medical repurchases 479,800 H-shares for HK$17.52 million, treasury stock rises to 1.62 million shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-24 19:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shenzhen Edge Medical Co., Ltd. (Edge Medical-B) disclosed that on 24 June 2026 it bought back 479,800 H-shares on the Hong Kong Stock Exchange. The purchase was executed entirely on-market under the company’s existing share-repurchase mandate dated 16 June 2025.</p>\n<p>The repurchased shares were acquired at prices ranging from HK$34.70 to HK$38.00 apiece, translating into a volume-weighted average cost of HK$36.53 per share and an aggregate consideration of HK$17.52 million. All repurchased shares have been retained as treasury stock.</p>\n<p>Following the transaction, Edge Medical’s outstanding share count (excluding treasury shares) fell by 0.1469% to 326.15 million shares, while the treasury stock balance increased to 1.62 million shares. The total issued share capital remains unchanged at 327.76 million shares until any future cancellation of treasury shares.</p>\n<p>Since receiving shareholder authorisation to repurchase up to 32.36 million shares, the company has cumulatively bought back 1.62 million shares, representing 0.50% of the issued shares outstanding on the mandate date. In accordance with Hong Kong listing rules, Edge Medical is subject to a moratorium on issuing new shares or disposing of treasury shares until 24 July 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02675","symbol_name":"精锋医疗-B","start_time":0,"source_url":"","article_id":"1129567789","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1129567789","pubTimestamp":1782300223,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shenzhen Edge Medical Co., Ltd. (Edge Medical-B) disclosed that on 24 June 2026 it bought back 479,800 H-shares on the Hong Kong Stock Exchange. The purchase was executed entirely on-market under the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02675":"精锋医疗-B"},"translate_title":"深圳边缘医疗1752万港元回购47.98万股H股库存股升至162万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02675":1},"content_text":"Shenzhen Edge Medical Co., Ltd. (Edge Medical-B) disclosed that on 24 June 2026 it bought back 479,800 H-shares on the Hong Kong Stock Exchange. The purchase was executed entirely on-market under the company’s existing share-repurchase mandate dated 16 June 2025.\nThe repurchased shares were acquired at prices ranging from HK$34.70 to HK$38.00 apiece, translating into a volume-weighted average cost of HK$36.53 per share and an aggregate consideration of HK$17.52 million. All repurchased shares have been retained as treasury stock.\nFollowing the transaction, Edge Medical’s outstanding share count (excluding treasury shares) fell by 0.1469% to 326.15 million shares, while the treasury stock balance increased to 1.62 million shares. The total issued share capital remains unchanged at 327.76 million shares until any future cancellation of treasury shares.\nSince receiving shareholder authorisation to repurchase up to 32.36 million shares, the company has cumulatively bought back 1.62 million shares, representing 0.50% of the issued shares outstanding on the mandate date. In accordance with Hong Kong listing rules, Edge Medical is subject to a moratorium on issuing new shares or disposing of treasury shares until 24 July 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.0","shortVersion":"4.45.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1129567789","isCrawlerRequest":true}